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ABSTRACT
Numerous studies have examined receptor
expression in neural transplants and their
possible role in transplant.induced functional
recovery from lesion-induced deficits. Herein we
attempt to summarize the results of these
studies, especially those from studies involving
striatal transplants. Autoradiographic studies
indicate that dopamine D1 and D2, muscarinic,
cholinergic, 5-HT2, opiate t, 13 adrenergic and
cholecystokinin (CCK) receptors are present in
striatal transplants. Many of these receptors are
present regardless of the transplant location and
surrounding environment. This suggests that the
expression of these receptors is determined by
intrinsic properties of transplanted tissue, and is
independent of transplant location and
environment. Some transplant receptors, such as
dopamine D1 and D2 and muscarinic receptors
in striatal transplants, or 5-HT2 receptors in
cortical transplants, display a patchy
distribution which is dissimilar to that in the
corresponding adult host tissue. This
manuscript discusses this "abnormal" receptor
distribution and possible explanations. Electro-
physiological studies have indicated that some of
the transplant receptors respond to physiological
and pharmacological stimulation, suggesting
that they are functional. However, the
association of receptor expression with
behavioral recovery is uncertain. The expression
of neurotransmitter receptors in neural
transplants may not be essential for the
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functional recovery associated with trophic
mechanisms. However, neurotransmitter
receptors may play an important role when
functional recovery requires neuroanatomical
integration between the host brain and the
transplanted tissue.
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INTRODUCTION
Numerous studies have demonstrated that fetal
brain tissues can survive transplantation and
develop some neuroanatomical and histochemical
features characteristic of mature tissues /7,22,28/.
Neural transplants can also ameliorate many
behavioral abnormalities induced by neurotoxic
lesions in animal models of Parkinson’s disease and
Huntingon’s disease /2,16,17,18,27,42,49,51,55/.
For example, transplants of fetal striatal tissue into
excitotoxin-lesioned striatum have been shown to
ameliorate the striatal lesion-induced abnormalities
in spontaneous behaviors, such as locomotor
activity/45,50/and skilled paw reaching behaviors
/16/, and also drug-induced deficits, including
apomorphine-induced rotational behavior /16,40,
43/, apomorphine and amphetamine-induced
locomotion /11,14,49/ and haloperidol-induced
catalepsy/19/. In addition, striatal transplants have
been reported to produce recoveries of lesion-
induced neurochemical deficits, such as for choline
acetyltransferase (CAT) and gamma-aminobutyric
acid (GABA)/28/.
Recent experiments have focused on the possible
mechanisms by which neural transplants promote
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behavioral recovery. One hypothesis is functional
anatomical integration between transplant and host.
Some specific afferent and efferent connections
between transplants and host have been reported
/2,4,45,63-65/. If these anatomical connections are
important for transplant-induced recovery,
neurotransmitter receptors will be required to
mediate these effects, since they are necessary for
synaptic signal transduction.
Several groups have studied receptor expression
and possible function in fetal striatal tissue
transplants/13,14,24,28,35,38,40,43,62/. Herein we
attempt to summarize the findings in this area and
discuss the development of receptors in transplants
and their possible role in transplant functions.
RECEPTOR EXPRESSION IN NEURAL
TRANSPLANTS
Several groups have demonstrated that fetal
striatal tissue can survive and express a variety of
receptors and transmitter specific neuronal markers.
The biochemical markers for intrinsic neurons
identified in striatal transplants include acetylcholin-
esterase (ACHE) /22,28,50,59/, met-enkephalin
(met-ENK), substance P (SP), somatostatin (SS),
cholecystokinin (CCK) and neuropeptide Y (NPY)
/22,28/.
Autoradiographic studies have demonstrated
that dopamineD and D2 muscarinic cholinergic, 5-
HT2, opiate t and 6, adrenergic [ and CCK
TABLE 1
Summary of the expression of neurotransmitter receptors and second messenger systems in fetal striatal tissue transplants
Study Donor Host Months Ligand/Receptor Result Functional
Post- Correlation
Graft
Beresford E13-15 [125I]CCK-8/CCK (+), patchy Reduction of
et al, cell rotational behavior
(I) suspen-
sion
Deckel E17-18 Female 6 Spiperone/D2 (-) Receptor density
et al, whole rat with dopamine inversely correlated
(ii) cell or with the locomotor
suspen- without hyperactivity following
sion KA lesion amphetamine and
apomorphine
125 Deckel El8 Adult 9 cyopindolol (+)
et al, female +ICI-89406/1
125 12 rat with cyanophldolol + the same
density as in host KA lesion +ICI-i18551/2 striatum
Deckel El7 Adult 8 NMS+carbachol/M1 (+) reduced
et al, cell female density
(13) suspen- rat with NMS+atropine/M2 (+) increased
sion KA lesion density
or without
Deckel El9 Adult 6 Spiperone/D2 et al, cell female
(14) suspen- rat with
sion KA lesion
or without
(+), patchy
Receptor density
correlated with the
sensorimotor and
alternation task, but
not correlated with
locomotor measurement,
inversely correlated
with behavior following
amphetamine and apomorphine
Receptor density
inversely correlated
with behavior
following amphetamine
and apomorphine injection
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Study Donor Host
TABLE 1 (cont.)
Months Ligand/Receptor Result
Post-
Graft
Functional
Correlation
Helm
et al,
(24)
Isacson
et al,
(2s)
Lanca
et al,
(33)
Lu
et al,
(36)
Mayer
et al,
(38)
Norman
et al,
(43)
E15-16 Adult
cell rats with
suspen- KA lesion
sion
E14-15
cell
suspen-
sion
E12-19 Rat pups
cell and
suspen- young
sion adult
E15-17 Adult
solid male rat
tissue with
intact
striatum
El5
cell
suspen-
sion
Adult
female
rat with
ibotenic
acid
lesion
El7 Male
solid adult
tissue rats with
KA lesion
4-6.5
1-3
1.5- 15
2.5
SCH23390/DI. (+), patchy
Splperone/D2 (-)
QNB/muscarinlc (+), even
Hemicholinlum/ (-)
high affinity
choline uptake
site
Forskolin/ (+), patchy
adenylate cyclase
Phorbol 12,13-
dibutyrate/
protein kinase C
Spiperone/D2
Diprenorphine/
opiate
PBCM/muscarinic
Etorphine/opiate
Spiperone/D2
SCH23390/D1
Spiperone/D2
Ketanserln/5-HT2
QNB/muscarinic
SCH23982/D1
Sulpirlde/D2
SCH23390/D1 (-)
Spiperone/D2 (-)
Forskolin / (-)
adenylate cyclase
(+), evenly throughout
the graft
(+), patchy
(+), patchy
(+), even
(+), patchy
(-)
(/), patchy
(+), patchy
(+), patchy
(+), even
(+), patchy
(+), patchy
No correlation with
the recovery of the
leslon-lnduced
rotational behavior
(+)
,,(-),,
NMS
PBCM
indicates the presence of receptors in the transplants
indicates the absence of receptors in the transplants
N-Methylscopolamine
Propylbenzilylcholine mustard
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receptors are present in striatal transplants/1,11,12,
13,14,24,28,33,36,38/ (results are summarized in
Table 1). These receptors are normally present in
adult rat striatum/21/. The density ofD dopamine
receptors in striatal transplants was reportedly
about 2 to 3-fold higher than that of dopamine D2
receptors /38/, which is similar to that in normal
striatum. The dopamine D and D2 and muscarinic
receptors were present in striatal transplants as early
as 6 weeks after transplantation /36/. In most
reports, the receptors were observed in striatal
transplants about 3-11 months after the implantation
(see Table 1).
However, the autoradiographic studies have also
shown some conflicting findings. Deckel et al./11/
initially reported the absence of dopamine D2
receptors in striatal transplants. Similarly, Norman
et al. /43/ reported an apparent lack of DI and D2
dopamine receptors within the transplant. However,
subsequent studies/36/, using transplants into non-
lesioned adult rat brain, reported the patchy
distribution of dopamine D and D2 receptors,
muscarinic receptors and the presence of 5-HT2
receptors in the striatal transplants. A recent study
by Helm et al. /24/ reported the absence of
dopamine D2 receptors in 4 and 6.5 month-old
transplants, which was consistent with the studies of
Norman et al. /43/ and Deckel et al. /11/. Dopamine
D receptors were also found to be absent at 4
months, consistent with the results of Norman et al.
/43/, but were reported to be present in sparse
patches at 6 months post transplant/24/.
When neurotransmitter receptors are found to be
expressed in transplanted fetal tissue the distribution
is often patchy. Less clear is the reason for the
apparent lack of or inconsistent receptor expression
in some studies. This relative lack of receptors in
transplants cannot be due to technical problems
with the autoradiographic assay procedure as
binding of the radioligand to appropriate receptors
in adjacent host tissues is apparent. Furthermore,
this inconsistency is not due to the different forms
of embryonic tissue transplanted, such as cell
suspension vs. tissue block, because in either case,
both positive and negative results have been
reported. Additionally, differences in receptor
expression between studies are apparent even from
the same laboratories. Deckel et al., although
initially reporting a lack of D2 dopamine receptors,
subsequently observed D2 dopamine receptors/14/.
A lack of D and D2 receptors was observed in
some studies /43/but subsequent studies using a
similar protocol of striatal transplants into non-
lesioned adult rat brain observed the patchy
distribution of both D and D2 dopamine receptors
/36/.
EXPRESSION OF TRANSPLANT INTRINSIC
RECEPTORS MAY BE INDEPENDENT OF
TRANSPLANT LOCATIONAND ENVIRONMENT
Normal striatum has relatively high levels of
dopamine D and D2 and muscarinic acetylcholine
receptors, high to moderate levels of adrenergic a
and [3, 5-HT and opiate receptors/9,21/. Expression
of receptors in neurons during normal development
may depend on genetic information. Additionally,
environmental cues, such as target innervation,
hormonal levels, etc., may also play an important
role. Studies on the expression of neurotransmitter
receptors in transplants placed in different locations
within the brain or into the anterior chamber of the
eye, provide information which may reflect the
influence of the local environment. For instance,
when striatal transplants were placed either into
striatum (homotopic location) or globus pallidus or
substantia nigra (ectopic locations), dopamine D2,
muscarinic and opiate receptors, in addition to the
neurochemical markers ACHE, SP, met-ENK and
NPY, were expressed in the tissues placed in all
locations. In addition, the distribution, uniform in
the case of muscarinic receptors and patchy in the
case of the other receptors and the neurochemical
markers, was independent of the location of the
transplant/28/. Even when striatal transplants were
placed in the lateral ventricle in which the
transplants were relatively isolated from anatomical
interactions, they were able to express D and D2
dopamine and muscarinic receptors /36,38/.
Similarly, many types of transplants can develop
appropriate neuronal neurochemical markers and
receptors when they are transplanted into the
anterior chamber of the eye/44/. In addition, fetal
striatal transplants expressed the same types of
receptors when they were placed either in
excitotoxin lesioned striatum or intact striatum
/13,14,28,36/.
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Neurotransmitter receptors have also been
identified in other types of transplants, for example,
ct and adrenergic receptors in intraocular
cerebellar transplants/20/, adrenergic receptors in
fetal cortical and cerebellar tissues transplanted into
cortex /34/, muscarinic and 5-HT receptors in
ventral mesencephalic and cortical tissues
transplanted into striatum /36/. Therefore, these
data suggest that the expression of appropriate
receptors and of some phenotypic neurochemical
markers in transplants is largely determined by
intrinsic environmental or genetic information rather
than extrinsic environmental factors.
However, this may not be true for certain
receptors which may depend on extrinsic
conditions, such as anatomical connections from the
host, for their expression and normal development.
The expression of opiate t receptors in homotopic
striatal transplants has been reported to require
innervation by host dopaminergic fibers/54/. Opiate
receptors have been reported to be located on
dopaminergic terminals originating from the
substantia nigra/54/. Therefore, this receptor maybe
extrinsic to striatal tissue and its expression within
intrastriatal transplants may reflect the ingrowth of
dopaminergic terminals from the host.
THE DISTRIBUTION OF RECEPTORS WITHIN
TRANSPLANTS IS DISSIMILARTO THAT IN HOST
Despite the presence of receptors with densities
sometimes similar to those observed in the host, the
distribution of receptors in transplants is clearly
different from that in the adult host. Some receptors
are found in very discrete areas within the transplant
often in relatively high densities, while in other areas
of the transplant the receptors are often absent. This
patchy receptor distribution characterizes dopamine
D and D2, and opiate t receptors in striatal
transplants /14,28,36,38,62/. The distribution of
muscarinic receptors has been described as patchy
or non-uniform in some studies /13,36/ but more
uniform in other studies/28/. 5-HT2 receptors have
been reported to be evenly distributed throughout
striatal transplants but patchy in cortical transplants
/36/. The patchiness of the distribution ofD1 and D2
dopamine and muscarini receptors in fetal striatal
transplants as well as the opiate kt receptor is
dissimilar to that in the host striatum. These patches
of relatively high receptor density have been
reported to correspond to the patches in the striatal
transplants that are rich in ACHE, met-ENK,
substance P, somatostatin and tyrosine hydroxylase
/28,66/. It was initially suggested that this patchy
distribution of receptors and neurochemical markers
may reflect the compartmentation known as
striosomes normally present during development
and in mature striatum/28,33/. However, Graybiel
et al. /22/ suggested that these high density patches
rich in a variety of the neurochemical markers may
have achieved a phenotype resembling normal
developing and mature striatum while the
histochemical features of the low density patches
were similar to immature striatum and non-striatal
tissues. The possibility was suggested that some
globus pallidus, basolateral amygdala and cortical
tissue was included during the dissection of fetal
striatum due to the proximity of these tissues to the
dissection area/22,28/.
The purity of transplanted fetal tissues can be
more easily maintained using fetal cortex as this
tissue is relatively large and clearly differentiated
from other areas of the fetal brain. In cortical
transplants clear lamination of 5-HT2 receptors
which was observed in the host cortex was not
seen. Instead, dispersed patches of 5-HT2 receptors
having relatively high density were intermingled
with low density areas/36/. From the corresponding
Nissl stained sections it was evident that this
patchiness of receptor density was not due to
uneven density of neurons within the transplant.
Furthermore, the muscarinic receptors in the same
transplant were evenly distributed. It is, therefore,
possible that the high density patches of 5-HT2
receptors were caused by clustering of the cortical
neurons that express high densities of 5-HT2
receptors. These high density patches may have
intermingled with cortical neurons expressing low
densities of 5-HT2 receptors, which in some degree
resembled the normal cortex, but with a disrupted
laminar organization. Alternatively, it is possible
that the neurons in the high receptor density regions
received a signal which stimulated the expression of
5-HT2 receptors while the neurons in the low
receptor density region did not receive such a
signal. However, there have been no systematic
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studies to evaluate these hypotheses. These data
suggest that the patchy distribution of some
neurotransmitter receptors, at least within cortical
transplants, is not due to the impurity of’ the
transplanted fetal tissue. Rather, although some
phenotypes of mature tissues can be expressed in
transplanted tissue, certain essential elements
required for complete normal organization of cells
or the development of receptors and other
neurochemical markers within the transplanted
tissue may have been missing or inadequate.
PHYSIOLOGICAL FUNCTION OF RECEPTORS IN
TRANSPLANTS
The physiological function of receptors in
striatal transplants has also been studied. Wichmann
and Starke /62/ have studied the effect of striatal
transplant-derived dopamine receptors and
muscarinic and opiate receptors on acetylcholine
release from transplants by measuring
[3H]acetylcholine effiux from slices of transplanted
striatum. They reported that the activation of
dopamine D2, muscarinic and opiate 5 receptors by
specific receptor agonists inhibited [3H]acetyl-
choline release from slices of transplanted striatum
which resembled the effect in normal striatum. This
effect increased with increasing concentration of the
agonists, and was abolished by appropriate receptor
antagonists. The results indicated that these
receptors had similar functions to the corresponding
receptors in normal striatum with regard to
modulation of acetylcholine release. In addition,
electrophysiological recording has revealed that the
synapses formed between transplant and host can be
functional. The response observed in transplants by
stimulation of the host neurons /2,25,48,61/ is
presumably mediated by neurotransmitters from the
stimulated host neurons acting on neurotransmitter
receptors present on the transplanted neurons.
Further evidence of functional receptors mediating
physiological activities comes from studies showing
that ct and 13 adrenergic receptors in intraocular
cerebellar transplants mediated the electro-
physiological effect of norepinephrine on Purkinje
neurons/20/. Furthermore, data from intracerebral
dialysis from intrastriatal nigral transplants indicated
that dopamine autoreceptors in nigral tranplants
may mediate the autoregulation of dopamine release
and metabolism/57/. A methamphetamine-induced
stimulation ofGABA release in the globus pallidus
and substantia nigra was also restored by striatal
tissue grafts into excitotoxin-lesioned striatum/54/,
suggesting that functional dopaminergic modulation
within the transplanted tissue of GABA output
neurons was re-established. These dopamine
receptors within both nigral and striatal transplants
may develop functions similar to those in mature
tissue.
In normal brain, some neurotransmitter
receptors are associated with the second messenger
system, adenylate cyclase /56/. Therefore, the
presence of second messenger systems in
transplanted tissues may be an indicator of
functional receptors. [3H]Forskolin binding has
been used to identify the stimulatory guanine
nucleotide regulatory subunit/adenylate cyclase
complex and its association with the D dopamine
receptors in transplants/24,43/. Norman et al. /43/
demonstrated a relative deficit of [3H]forskolin
binding sites corresponding to the lack of D
dopamine receptors in the striatal transplants at 12
weeks post transplant. A recent study by Helm et
al. /24/ reported the presence of a patchy
distribution of [3H]forskolin binding sites in 6
month-old transplants which was similar to the D
dopamine receptor patches in the striatal transplant,
again suggesting their possible association.
[3H]Phorbol ester binding to protein kinase C,
another second messenger system, was present in
the transplanted striatal tissue, but in contrast to the
dispersed patches of [3H]forskolin binding, protein
kinase C was very prominent throughout the
transplant/24/. The available data suggest that D
dopamine receptors when present in striatal
transplants are associated with the presence of
adenylate cyclase and protein kinase C, though not
necessarily in a normal stoichiometric relationship.
However, there are no studies to date to determine
whether receptor agonists elicit activation of second
messenger systems within transplants. Such studies
would be technically difficult. However, indirect
evidence might come from the measurement of the
expression of immediate-early response gene
products /15/. The expression of such proto-
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oncogenes, for example c-fos, can be stimulated by
a number of neurotransmitters and receptor
agonists. For example, D-amphetamine or cocaine
elicits a marked expression of c-fos in rat striatum
through indirect activation of dopamine receptors,
especially of the D subtype/23,47/. Therefore, the
amphetamine-induced activation of c-fos in fetal
tissue transplants might indicate the presence of
functional monoaminergic synapses in the
transplanted tissues. In cortical and striatal tissues
transplanted into rat striatum most of the
dopaminergic innervation would be from the host.
The expression of czfi)s in the transplants could be
indicative of functional D dopamine receptors on
the transplanted neurons. Amphetamine was able to
stimulate the expression of fos-like immuno-
reactivity in fetal striatal grafts transplanted into
intact adult striatum /37/. This amphetamine-
induced stimulation of c-fos was abolished by
dopamine deafferentation of the host striatum /37/
implying that functional innervation of the
transplanted tissue mediated the response.
Furthermore, this same study found that the directly
acting dopamine receptor agonist, apomorphine,
was able to stimulate the expression of fos-like
immunoreactivity in the intrastriatal graft following
the dopamine deafferentation. Interestingly,
apomorphine is able to stimulate the expression of
c-fos in dopamine deafferented, but not in intact rat
striatum. Presumably, this is due to a requirement
for supersensitive dopamine receptors for the
apomorphine-induced expression of c-los.
Therefore, the data of Mandel et al. /37/ implied
that dopamine receptors were present in the
transplant and had the same pharmacological
characteristics and were under the same regulatory
mechanisms as were the receptors in the adult
striatum.
Although muscarinic cholinergic receptors
develop in fetal striatal grafts this population of
receptors may consist of an abnormal ratio of
pharmacologically defined receptor subtypes.
Deckel et al. /13/ reported that the number of
putative M receptors was reduced while the
number of putative M2 receptors was increased.
This may indicate some abnormality of receptor
development which in turn may cause abnormal
signal transduction. However, the significance of
these findings is unclear as the use of agonist
displacement of non-selective muscarinic
antagonists can be complex. It was assumed /13/
that the agonist displaceable [3H]N-methyl
scopolamine (NMS) binding represented a distinct
muscarinic receptor subtype (M2) while the
remaining binding of the [3H]NMS represented the
M muscarinic receptor. However, the M
muscarinic receptor sub,type has also been
demonstrated to have both high and low affinity
agonist states/39/. Furthermore, the binding of the
quaternary antagonist [3H]NMS is complex /41/,
making such agonist displacement studies even
more difficult to interpret. It is more likely that the
’M2 receptor’ represented the high affinity agonist
states of a number of muscarinic receptor subtypes
rather than a single population of pharmacologically
distinct receptors. Conversely, the ’M receptor’
would represent the low affinity agonist states of
these same multiple receptors. The reported
changes in agonist competition would indicate that
the number of muscarinic receptors in the high
affinity agonist state was increased in the transplant
relative to the adult host. As the agonist affinity
states are determined by coupling to guanine
nucleotide regulatory subunits /39/ there may be
alterations in cholinergic signal transduction
mechanisms in the transplanted tissue.
There was a lack of high affinity choline uptake
sites in striatal transplants in spite of the presence of
a high density of muscarinic cholinergic receptors,
suggesting that few functional cholinergic terminals
were present in the transplants /24/. Furthermore,
the development of alpha-bungarotoxin binding
sites in fetal tectum transplanted into rat midbrain
occurs independently of inputs from the host brain
or functional cholinergic innervation/58/. Thus, the
functional significance of the muscarinic or putative
nicotinic receptors present in the transplants is not
clear.
Studies also revealed that some transplant
receptor function is conditional and dependent on
specific host-transplant anatomical connections and
integration. For example, opiate receptor agonists
failed to enhance the stimulation-evoked
acetylcholine release in slices of transplants /62/.
This effect was observed in normal striatal slices
which depended on a dopaminergic input to the
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cholinergic cells. This suggests that opiate
receptor function is dependent not only on the
expression of the receptor but also on the
integration of the host dopaminergic system with
the transplanted tissue. However, it is not clear
from these studies whether this dependence of
opiate : receptor-mediated responses on
dopaminergic innervation reflects the localization of
these receptors on dopaminergic fibers as suggested
for the opiate g receptor/54/.
The response of physiologically functional
receptors within transplants can be inferred from
electrophysiological studies and from the agonist-
induced modulation of transmitter release from
transplant slices. However, there are also some
receptors present in regions of transplants which do
not appear to have the appropriate neuronal
innervation. Therefore, the functional relevance of
these receptors under in vivo conditions is unclear
unless they can be activated by neuroactive
compounds diffusing from non-local sources.
POSSIBLE FUNCTION OF RECEPTORS IN
PROMOTING BEHAVIORAL RECOVERY
Striatal transplants have been demonstrated to
be able to reverse many behavioral deficits induced
by striatal excitotoxin lesions /2,16,27,42,51/.
However, the association between the expression of
receptors in transplants and transplant-induced
behavioral recovery from lesion-induced deficits is
uncertain. For example, it has been reported that the
transplant-induced amelioration of apomorphine-
induced turning behavior following unilateral
excitotoxin lesions of the adult striatum appeared to
be independent of the presence of receptors in the
transplant /43/. Whether or not transplant-derived
receptors play a role in behavioral modulation may
be dependent on a variety of factors, such as the
degree of integration of the receptors with
appropriate host circuitry, and/or whether the
function mediated via the particular receptors
requires local circuits or specific anatomical
connections with the host. It is also possible that
neurotrophic factors released from transplants may
be at least partially responsible for early recovery of
drug-induced rotation behavior. The recovery of
unilateral excitotoxin lesion-induced rotational
behavior was reported as early as 5 weeks following
transplantation/40,42,43/. At this time, there is no
clear evidence for substantial connectivity between
host and transplant/59/. Therefore it is possible that
trophic factors or other agents may diffuse from the
transplant into surrounding host tissue and promote
regenerative activity of the remaining host tissue.
Indeed, it has been suggested that transplants of
adrenal medulla into dopaminergic deafferented rat
striatum can induce sprouting of the remaining host
dopaminergic fibers, presumably via a trophic
mechanism /3/. Trophic factors have also been
demonstrated to be produced in the brain in
response to injury, and transplants of fetal tissues
have been suggested to restore function in part by
providing trophic support to the remaining host
tissues /5,6/. Receptors within the transplant may
not be essential for this putative aspect of transplant
function. However, for recovery of other motor
tasks, for example, skilled paw reaching in rats/16/,
higher levels of anatomical and functional
integration, including receptors, may be required. It
has been demonstrated that many transplant-host
connections were established in the same patches in
which a high density of receptors were present and
that were also rich in appropriate neurochemical
markers /28/. Therefore, it is conceivable that in
these areas the receptors in transplants may actively
modulate the recovery of more complex host
functions.
In addition to host modulation of receptors in
the transplanted tissue, neurotransmitter receptors
in the host brain can be modulated by transplanted
tissue. For instance, intrastriatal ventral
mesencephalic transplants were reported to be able
to correct dopamine receptor supersensitivity in the
striatum following lesion of the nigro-striatal
dopaminergic pathway in rats /10,17,46/.
Interestingly, in the post-mortem striatum of a
patient with Parkinson’s disease who had received
an autologous transplant of adrenal medulla/26,31/,
a marked decrease in the levels of ’supersensitive’
D dopamine receptors was observed returning the
receptor levels to those observed in control striatum
/31/. A decrease in the elevated levels of D2
dopamine receptors was also observed in specific
regions of the caudate, though the effects were not
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as great as observed for D dopamine receptors
/31/. This relative normalization of dopamine
receptors was restricted to the area immediately
surrounding the surviving transplanted cells where
there was also an increase in [3H]mazindol binding
indicating an increased density of dopaminergic
terminals. Thus, the localized increase in
dopaminergic innervation of the human striatum
(possibly due to graft-induced sprouting of
remaining host dopaminergic fibers) also appears to
elicit changes in levels of dopaminergic receptors in
the host striatum.
This relative normalization by fetal transplants of
neurotransmitter receptors in the host brain is not
restricted to striatum. Cholinergic deafferentation of
the rat hippocampus elicits a location-specific
increase in muscarinic receptors. Following
transplantation of fetal septum into the lesioned
hippocampus, an increase in cholinergic markers is
observed concomitant with a normalization of the
levels ofmuscarinic receptors/8,29,30,52/.
There is also some indirect evidence of fetal
tissue transplants modulating receptor sensitivity in
the unlesioned rat striatum. Transplantation of
various fetal tissues into the intact adult striatum
elicited a hyporesponsiveness to most locomotor
behaviors induced by amphetamine or by doses of
apomorphine which predominantly activate
postsynaptic dopamine receptors/35/. Furthermore,
the transplanted rats displayed significantly greater
catalepsy than normal rats following the injection of
the dopamine receptor antagonist haloperidol /3 5/.
These data are consistent with a decreased
sensitivity of postsynaptic dopamine receptors.
These effects were produced by transplants of
different fetal tissues not all of which expressed
dopamine receptors /36/. This suggested that the
transplants produced a common effect in the host
striatum. A hypersensitivity to the locomotor
inhibiting effects of a lower dose of apomorphine
which is relatively selective for autoreceptor
activation was observed/35/. This suggested that an
increase in the sensitivity of presynaptic dopamine
receptors could be elicited in the host striatum by
transplants. That the transplanted tissue is capable
of modulating the function of the host brain in this
way demonstrates an important principle of
neuroplasticity in adult brain. Clearly transplanted
tissues may be capable of inducing many
neurochemical and physiological responses in adult
host brain. Thus, functional recovery of lesion-
induced deficits following neural transplantation
might also be produced by transplant-induced
receptor plasticity ofthe adult host brain.
Receptors are key components of signal
propagation and also important elements of
neuroplasticity /32/. Long term changes in the
concentration of transmitters may result in changes
in the sensitivity of receptor-mediated responses.
Transplants of neuronal tissue into host brain will
introduce new tissue into the host which may
produce a variety of factors, including neurotrophic
factors and neurotransmitters. These transplant-
derived factors may elicit a reorganization of the
host tissue. Alternatively, the host may also
influence transplant function by modulating its
neuronal activity, possibly via changes in receptor
sensitivity.
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